Harvard researchers have found that M. morganii may contribute to depression by producing an inflammatory molecule.

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

While there are many treatment options for depression, natural remedies, self-care methods, and alternative therapies can ...

A compelling new study is building on a growing body of evidence showing a common exercise supplement used to build muscle ...

A new study from the University of Chicago Medicine reveals that people with alcohol use disorder (AUD) and depression experience high levels of stimulation and pleasure when intoxicated, similar to ...

Depressed drinkers experience alcohol’s pleasure and stimulation, challenging beliefs about self-medication and addiction.

Monty Minter, director of the Downing Counseling Clinic, shares strategies for finding light during the darker months ...

In JASA Express Letters, researchers develop machine learning tools that screen for comorbid anxiety disorders and major ...

Neurocrine Biosciences amended its agreement with Takeda Pharmaceutical regarding the development and commercialization of osavampator, a treatment for major depressive disorder.

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) amended its agreement with Takeda Pharmaceutical Co Ltd (NYSE:TAK) to develop and ...

The therapy scored a phase 2 win last year by showing that it significantly reduced depression severity among adults with major depressive disorder (MDD) who haven’t benefited from at least one ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.